Established technology, operational infrastructure, and nursing resources were leveraged to develop a remote patient monitoring (RPM) program for ambulatory management of patients with COVID-19. The program included two care-delivery models with different monitoring capabilities supporting variable levels of patient risk for severe illness. The primary objective of this study was to determine the feasibility and safety of a multisite RPM program for management of acute COVID-19 illness. We report an evaluation of 7074 patients served by the program across 41 US states. Among all patients, the RPM technology engagement rate was 78.9%. Rates of emergency department visit and hospitalization within 30 days of enrollment were 11.4% and 9.4%, respectively, and the 30-day mortality rate was 0.4%. A multisite RPM program for management of acute COVID-19 illness is feasible, safe, and associated with a low mortality rate. Further research and expansion of RPM programs for ambulatory management of other acute illnesses are warranted.

利用成熟的技术、运营基础设施和护理资源来开发远程患者监测 (RPM) 计划，以对 COVID-19 患者进行门诊管理。该计划包括两种具有不同监测能力的护理提供模型，支持不同级别的重症患者风险。本研究的主要目的是确定用于管理急性 COVID-19 疾病的多站点 RPM 计划的可行性和安全性。我们报告了对该计划在美国 41 个州服务的 7074 名患者的评估。在所有患者中，RPM 技术参与率为 78.9%。入组后30天内急诊就诊率和住院率分别为11.4%和9.4%，30天死亡率为0.4%。用于管理急性 COVID-19 疾病的多站点 RPM 计划是可行的、安全的，并且与低死亡率相关。有必要进一步研究和扩展用于其他急性疾病的门诊管理的 RPM 计划。